Dunhill Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Dunhill Financial’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$84	–	1640
2026 Q1	$84	Hold	2	–	–	﹤0.01%	1468
2025 Q4	$53	Buy	+2	New	+$47	﹤0.01%	1638

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dunhill Financial's APLS Position: Q2 2026 in Review

Dunhill Financial sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2 shares — an estimated $84 sold.

Dunhill Financial first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $84 in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Dunhill Financial reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 2 Apellis Pharmaceuticals shares in Q2 2026, an estimated $84.
Dunhill Financial first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Dunhill Financial's Apellis Pharmaceuticals position peaked at $84 in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.